Company: TBPH
Filing Date: 2025-06-02
Form Type: 8-K
Source: 0001104659-25-055100
Chunk: 3

Company: Theravance Biopharma, Inc.
Filing Date: 2025-06-02
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

   2.1      Assignment Agreement, dated May 30, 2025, by and between Theravance Biopharma, Inc. and GlaxoSmithKline Intellectual Property Development Limited, a private company limited by shares registered...  
  99.1      Press Release dated June 2, 2025                                                                                                                                                                      
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
   104      Cover Page Interactive Data File (cover page XBRL tags embedded within the Inline XBRL document)                                                                                                      

SIGNATURE